CritiTech Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

CritiTech General Information

Description

Manufacturer of particle compounds intended to micronize a wide variety of small-molecule and biotechnology drugs. The company's fine-particle compounds utilize its carbon dioxide technology to develop potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations, enabling pharmacists to develop and differentiate drugs and medical devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1849 East 1450 Road
  • PO Box 442280
  • Lawrence, KS 66044
  • United States
+1 (785)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 1849 East 1450 Road
  • PO Box 442280
  • Lawrence, KS 66044
  • United States
+1 (785)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CritiTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 10-Jul-2023 Completed Generating Revenue
11. Debt - PPP 29-Apr-2020 Completed Generating Revenue
10. Later Stage VC 01-Apr-2019 Completed Generating Revenue
9. Later Stage VC 21-Aug-2014 Completed Generating Revenue
8. Later Stage VC 14-Feb-2013 Completed Generating Revenue
7. Angel (individual) 31-Dec-2010 Completed Generating Revenue
6. Later Stage VC 10-Dec-2009 Completed Generating Revenue
5. Later Stage VC 02-Dec-2008 Completed Generating Revenue
4. Early Stage VC 15-Feb-2005 $480K $480K Completed Generating Revenue
3. Grant 04-Aug-2004 $100K Completed Generating Revenue
To view CritiTech’s complete valuation and funding history, request access »

CritiTech Patents

CritiTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4608414-A2 Cisplatin particles and uses thereof Pending 25-Oct-2022
EP-4608414-A4 Cisplatin particles and uses thereof Pending 25-Oct-2022
US-20240156861-A1 Cisplatin particles and uses thereof Pending 25-Oct-2022
WO-2024091869-A2 Cisplatin particles and uses thereof Inactive 25-Oct-2022
WO-2024091869-A3 Cisplatin particles and uses thereof Inactive 25-Oct-2022 A61K9/10
To view CritiTech’s complete patent history, request access »

CritiTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CritiTech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerate Venture Partners Angel Group Minority
Angel (individual) Minority
eGrowth Ventures Not-For-Profit Venture Capital Minority
KTECH Capital PE/Buyout Minority
Precede Fund Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

CritiTech Investments (2)

CritiTech’s most recent deal was a Corporate with NanOlogy (Pharmaceutical) for . The deal was made on 01-Jan-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NanOlogy (Pharmaceutical) 01-Jan-2017 Corporate Drug Discovery
NanOlogy (Pharmaceutical) 01-Jan-2015 Joint Venture Drug Discovery
To view CritiTech’s complete investments history, request access »

CritiTech FAQs

  • When was CritiTech founded?

    CritiTech was founded in 2001.

  • Where is CritiTech headquartered?

    CritiTech is headquartered in Lawrence, KS.

  • What is the size of CritiTech?

    CritiTech has 18 total employees.

  • What industry is CritiTech in?

    CritiTech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is CritiTech a private or public company?

    CritiTech is a Private company.

  • What is CritiTech’s current revenue?

    The current revenue for CritiTech is .

  • How much funding has CritiTech raised over time?

    CritiTech has raised $18.3M.

  • Who are CritiTech’s investors?

    Accelerate Venture Partners, , eGrowth Ventures, KTECH Capital, and Precede Fund are 5 of 8 investors who have invested in CritiTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process